Roche COVID-19 response
Roche & COVID-19
About Roche Clinical Trials
On Wednesday 11th March the World Health Organization (WHO) declared a pandemic in response to the COVID-19 outbreak. This is a serious health situation and we extend our sympathies to people who have lost loved ones, to patients and healthcare professionals. We recognise that the public and private sectors across the globe need to work together to help effectively manage this developing situation.
The COVID-19 pandemic continues to evolve rapidly and we are doing everything we can to contribute. Our people are working day and night to increase wherever possible the supply of key tests and medicines, we are partnering with local authorities and organisations to support front line healthcare providers, and we are continuing to help make sure that patients - many of whom have very serious illnesses - receive the treatment and care they need.
Investigating treatment options
Under exceptional conditions around the world, colleagues at Roche are doing everything they can to ensure that patients – many of whom have very serious illnesses – receive the treatment and care they need and that we keep a complex value chain of diagnostics and medicines going and ensure continuity of care for other conditions.
While we respond to COVID-19, we also continue to deliver medicines and diagnostics wherever possible for patients across a broad range of other disease areas under exceptional conditions.
Public and private sectors across the globe must work together to address this challenge.
Throughout the world there is intensive cooperation among industry, customers, nonprofits, governments and regulatory bodies to ensure we support where we can to contain the coronavirus. We call on governments to keep borders and global supply lines open for medical equipment and supplies, so that medicines and tests can reach the people who need them most.
In these exceptional times, Roche stands shoulder to shoulder with governments, healthcare providers and all those working to overcome the pandemic.
Delve into this virtual panel with @pravenenath, Roche Global Head for Digital Health, during#WorldHealthAssemblywhere in collaboration with @HIMSS global health experts and policymakers discuss how#health系统可以使用#digitalhealthto respond to#COVID19和beyondhttps://t.co/8esr7sjnln.pic.twitter.com/Yn9ZbYleGF— Roche (@Roche)April 14, 2020
The most important thing is our individual contribution to help flatten the curve by minimising the risk of infection. This is crucial, as it relieves the healthcare systems and helps patients around the world.”
COVID-19 and the mysterious world of antibodies
Timothy Tellinghuisen, Head of Virology Discovery, explains why understanding antibodies could hold the key in tackling COVID-19 and other pandemics.more
A global health crisis inspires unique partnerships
In the race to detect and treat COVID-19, biotech, government and academia are joining forces to battle a disease that knows no borders.more